Cellebrite DI Ltd.
NASDAQ:CLBT
19.64 (USD) • At close April 25, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Revenue
| 401.203 | 325.11 | 270.651 | 246.246 | 194.913 | 171.854 |
| Cost of Revenue
| 62.593 | 53.231 | 50.746 | 42.557 | 37.879 | 35.823 |
| Gross Profit
| 338.61 | 271.879 | 219.905 | 203.689 | 157.034 | 136.031 |
| Gross Profit Ratio
| 0.844 | 0.836 | 0.813 | 0.827 | 0.806 | 0.792 |
| Reseach & Development Expenses
| 98.415 | 84.386 | 80.62 | 65.541 | 54.377 | 46.573 |
| General & Administrative Expenses
| 50.9 | 43.443 | 40.854 | 47.937 | 29.861 | 28.618 |
| Selling & Marketing Expenses
| 132.389 | 110.813 | 97.387 | 76.389 | 61.305 | 61.61 |
| SG&A
| 183.289 | 154.256 | 138.241 | 124.326 | 91.166 | 90.228 |
| Other Expenses
| 0 | 0 | 0 | 0 | 2.273 | 0.75 |
| Operating Expenses
| 281.704 | 238.642 | 218.861 | 189.867 | 147.816 | 137.551 |
| Operating Income
| 56.906 | 33.237 | 1.044 | 13.822 | 9.218 | -1.332 |
| Operating Income Ratio
| 0.142 | 0.102 | 0.004 | 0.056 | 0.047 | -0.008 |
| Total Other Income Expenses Net
| -332.89 | -108.8 | 119.716 | 68.483 | 2.179 | 2.935 |
| Income Before Tax
| -275.984 | -75.563 | 120.76 | 82.305 | 11.397 | 1.415 |
| Income Before Tax Ratio
| -0.688 | -0.232 | 0.446 | 0.334 | 0.058 | 0.008 |
| Income Tax Expense
| 7.023 | 5.537 | -0.045 | 10.909 | 5.616 | 3.291 |
| Net Income
| -283.007 | -81.1 | 120.805 | 71.396 | 5.781 | -1.876 |
| Net Income Ratio
| -0.705 | -0.249 | 0.446 | 0.29 | 0.03 | -0.011 |
| EPS
| -1.35 | -0.43 | 0.64 | 0.5 | 0.047 | -0.01 |
| EPS Diluted
| -1.35 | -0.43 | 0.59 | 0.44 | 0.047 | -0.01 |
| EBITDA
| 67.513 | -64.799 | 10.238 | 89.876 | 16.945 | 2.747 |
| EBITDA Ratio
| 0.168 | -0.199 | 0.038 | 0.365 | 0.087 | 0.016 |